Tower Research Capital (TRC)’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$92.5K Buy
6,421
+2,835
+79% +$40.9K ﹤0.01% 2446
2025
Q1
$24.7K Buy
3,586
+2,318
+183% +$16K ﹤0.01% 2775
2024
Q4
$6.73K Sell
1,268
-2,102
-62% -$11.2K ﹤0.01% 4142
2024
Q3
$12.3K Sell
3,370
-9,508
-74% -$34.7K ﹤0.01% 3602
2024
Q2
$35.2K Buy
12,878
+12,778
+12,778% +$34.9K ﹤0.01% 3366
2024
Q1
$348 Buy
100
+91
+1,011% +$317 ﹤0.01% 5537
2023
Q4
$13 Sell
9
-4,439
-100% -$6.41K ﹤0.01% 5834
2023
Q3
$6.49K Buy
4,448
+3,551
+396% +$5.18K ﹤0.01% 4589
2023
Q2
$1.41K Sell
897
-4,453
-83% -$6.99K ﹤0.01% 5358
2023
Q1
$9K Sell
5,350
-13,489
-72% -$22.7K ﹤0.01% 4560
2022
Q4
$31K Buy
18,839
+5,528
+42% +$9.1K ﹤0.01% 2728
2022
Q3
$16K Sell
13,311
-27,030
-67% -$32.5K ﹤0.01% 4146
2022
Q2
$67K Buy
40,341
+35,071
+665% +$58.2K ﹤0.01% 2627
2022
Q1
$13K Buy
5,270
+740
+16% +$1.83K ﹤0.01% 4009
2021
Q4
$17K Sell
4,530
-5,601
-55% -$21K ﹤0.01% 3877
2021
Q3
$64K Buy
10,131
+8,069
+391% +$51K ﹤0.01% 2766
2021
Q2
$20K Sell
2,062
-32,037
-94% -$311K ﹤0.01% 3902
2021
Q1
$319K Buy
34,099
+15,814
+86% +$148K 0.01% 1624
2020
Q4
$88K Sell
18,285
-28,149
-61% -$135K ﹤0.01% 2478
2020
Q3
$186K Buy
46,434
+36,743
+379% +$147K ﹤0.01% 2646
2020
Q2
$44K Buy
9,691
+6,341
+189% +$28.8K ﹤0.01% 3146
2020
Q1
$11K Buy
3,350
+1,524
+83% +$5K ﹤0.01% 1996
2019
Q4
$8K Sell
1,826
-2,952
-62% -$12.9K ﹤0.01% 2473
2019
Q3
$19K Buy
+4,778
New +$19K ﹤0.01% 2519
2019
Q1
Sell
-4,545
Closed -$16K 4364
2018
Q4
$16K Buy
4,545
+4,324
+1,957% +$15.2K ﹤0.01% 2132
2018
Q3
$1K Sell
221
-614
-74% -$2.78K ﹤0.01% 3640
2018
Q2
$3K Buy
+835
New +$3K ﹤0.01% 3264
2017
Q4
Sell
-1,159
Closed -$5K 4199
2017
Q3
$5K Buy
1,159
+487
+72% +$2.1K ﹤0.01% 3339
2017
Q2
$3K Buy
+672
New +$3K ﹤0.01% 2254
2017
Q1
Sell
-572
Closed -$2K 4062
2016
Q4
$2K Buy
+572
New +$2K ﹤0.01% 3483
2016
Q3
Sell
-1,089
Closed -$5K 4586
2016
Q2
$5K Buy
+1,089
New +$5K ﹤0.01% 3427